Oxford Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Oxford Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-63,655	Closed	-$1.52M	–	1683
2019 Q4	$1.52M	Buy	63,655 +46,812	+278%	+$1.29M	0.04%	594
2019 Q3	$452K	Buy	+16,843	New	+$473K	0.01%	1299
2019 Q2	–	Sell	-19,932	Closed	-$692K	–	2072
2019 Q1	$692K	Buy	19,932 +6,595	+49%	+$190K	0.02%	1093
2018 Q4	$260K	Buy	+13,337	New	+$274K	0.01%	1453
2018 Q1	–	Sell	-39,141	Closed	-$1.86M	–	2011
2017 Q4	$1.86M	Buy	39,141 +23,678	+153%	+$1.2M	0.04%	613
2017 Q3	$827K	Sell	15,463 -33,794	-69%	-$1.98M	0.02%	1025
2017 Q2	$2.77M	Sell	49,257 -19,403	-28%	-$777K	0.06%	445
2017 Q1	$2.69M	Buy	68,660 +18,909	+38%	+$602K	0.07%	327
2016 Q4	$1.12M	Sell	49,751 -265,046	-84%	-$5.18M	0.04%	451
2016 Q3	$7.15M	Buy	314,797 +117,598	+60%	+$2.76M	0.22%	112
2016 Q2	$4.65M	Buy	+197,199	New	+$4.87M	0.15%	161
2016 Q1	–	Sell	-41,323	Closed	-$2.14M	–	953
2015 Q4	$2.14M	Buy	+41,323	New	+$2M	0.05%	385

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Oxford Asset Management's PTLA Position: Q1 2020 in Review

Oxford Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 63,655 shares — an estimated $1.52M sold.

Oxford Asset Management first reported a position in PTLA in Q4 2015 and held it in 12 quarters. The position peaked at $7.15M in Q3 2016. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Oxford Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 63,655 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.52M.
Oxford Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 12 quarters.
Oxford Asset Management's Portola Pharmaceuticals, Inc. position peaked at $7.15M in Q3 2016.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.